title: [The effect of leukotriene C4/D4 receptor antagonist (ONO-1078) and thromboxane A2 synthetase inhibitor (OKY-046) on airway hyperresponsiveness induced by ozone exposure in guinea pigs].
abstract: To clarify the mechanisms of ozone-induced airway hyperresponsiveness, we studied the effect of leukotriene C4/D4 receptor antagonist (ONO-1078) and thromboxane A2 synthetase inhibitor (OKY-046) on airway hyperresponsiveness induced by ozone exposure in guinea pigs. Airway responsiveness to inhaled methacholine was determined in artificially ventilated guinea pigs using a modification of the Konzett-Rössler technique. After the methacholine challenge, bronchoalveolar lavage (BAL) was performed. After 1 hour following ozone exposure (2.9 ppm, 30 min), airway responsiveness increased significantly. There was no cellular change in the bronchoalveolar lavage fluid (BALF). Pretreatment with ONO-1078 (30 mg/kg, i.p.) or OKY-046 (20 mg/kg, i.p.) caused no effect on airway responsiveness before ozone exposure, and inhibited the increase of airway responsiveness induced by ozone exposure. These results suggest that leukotriene and thromboxane play an important role in the development of airway hyperresponsiveness induced by ozone exposure in guinea pigs.
authors.affiliation: First Department of Internal Medicine, School of Medicine, Showa University, Tokyo, Japan.
authors.forename: A
authors.initials: A
authors.lastname: Okazawa
authors.forename: H
authors.initials: H
authors.lastname: Kobayashi
authors.forename: M
authors.initials: M
authors.lastname: Adachi
authors.forename: T
authors.initials: T
authors.lastname: Takahashi
authors.forename: M
authors.initials: M
authors.lastname: Misawa
mesh_terms: D000179:Acrylates / Q000494:pharmacology*; D000280:Administration, Inhalation; D000818:Animals; D001980:Bronchi / Q000187:drug effects*; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology; D002867:Chromones / Q000494:pharmacology*; D006168:Guinea Pigs; D016210:Methacholine Chloride; D008688:Methacholine Compounds / Q000494:pharmacology; D008689:Methacrylates / Q000494:pharmacology*; D009119:Muscle Contraction / Q000187:drug effects; D010126:Ozone / Q000009:adverse effects*; D011971:Receptors, Immunologic / Q000037:antagonists & inhibitors*; D018077:Receptors, Leukotriene; D013928:Thromboxane A2 / Q000096:biosynthesis
chemical_list: D000179:Acrylates; D002867:Chromones; D008688:Methacholine Compounds; D008689:Methacrylates; D011971:Receptors, Immunologic; D018077:Receptors, Leukotriene; D016210:Methacholine Chloride; D013928:Thromboxane A2; D010126:Ozone; C034364:ozagrel; C047681:pranlukast